Bayer logo

Bayer

Stock
Stock
ISIN: DE000BAY0017
Ticker: BAYN
DE000BAY0017
BAYN

Price

Price

CHART BY

Historical dividends and forecast

All dividend data

Bayer has so far distributed $0.118 in 2024. The next dividend will be paid on 02.05.2025


$2.302

CHART BY

Frequently asked questions

What is Bayer's market capitalization?

The market capitalization of Bayer is $19.40B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is the Earnings Per Share (EPS) for Bayer?

Bayer's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$0.934. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for Bayer's stock?

Currently, 20 analysts cover Bayer's stock, with a consensus target price of $27.52. Analyst ratings provide insights into the stock's expected performance.

What is Bayer's revenue over the trailing twelve months?

Over the trailing twelve months, Bayer reported a revenue of $48.75B.

What is the EBITDA for Bayer?

Bayer's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $11.59B. EBITDA measures the company's overall financial performance.

What is the free cash flow of Bayer?

Bayer has a free cash flow of $4.23B. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.

How many employees does Bayer have, and what sector and industry does it belong to?

Bayer employs approximately 99,723 people. It operates in the Health Care sector, specifically within the Pharmaceuticals: Major industry.

What is the free float of Bayer's shares?

The free float of Bayer is 982.40M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap 
$19.40B
EPS (TTM) 
-$0.934
Free Float 
982.40M
Revenue (TTM) 
$48.75B
EBITDA (TTM) 
$11.59B
Free Cashflow (TTM) 
$4.23B

Pricing

1D span
$19.28$19.81
52W span
$19.25$39.50

Analyst Ratings

The price target is $27.52 and the stock is covered by 20 analysts.

Buy

4

Hold

16

Sell

0

Information

Bayer AG engages in the business of life science fields of healthcare and nutrition. It operates through the following segments: Crop Science, Pharmaceuticals, and Consumer Health. The Crop Science segment includes developing, producing, and marketing products in seeds and plant traits, crop protection, digital solutions, and customer services to promote sustainable agriculture. The Pharmaceuticals segment is involved in prescription products especially for cardiology and women’s health; specialty therapeutics in the areas of oncology, hematology, ophthalmology, and cell and gene therapy; diagnostic imaging equipment; and necessary contrast agents. The Consumer Health segment focuses on non-prescription products in the dermatology, nutritional supplements, digestive health, allergy, cough and cold, and pain and cardiovascular risk prevention categories. The company was founded by Friedrich Bayer and Johann Friedrich Westkott on August 1, 1863 and is headquartered in Leverkusen, Germany.

Employees
99,723
Industries
Pharmaceuticals: Major
Sector
Health Care

Identifier

ISIN
DE000BAY0017
Primary Ticker
BAYN

Knockouts

Join the conversation